Xie Y - Search Results

1

A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.

Zhang L, Xu Y, Jin X, Wang Z, Wu Y, Zhao D, Chen G, Li D, Wang X, Cao H, Xie Y, Liang Z. Zhang L, et al. Among authors: xie y. Breast Cancer Res Treat. 2015 Nov;154(2):423-34. doi: 10.1007/s10549-015-3591-0. Epub 2015 Oct 17. Breast Cancer Res Treat. 2015. PMID: 26476723

2

p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer.

Xu Y, Yao L, Ouyang T, Li J, Wang T, Fan Z, Lin B, Lu Y, Xie Y. Xu Y, et al. Among authors: xie y. Clin Cancer Res. 2005 Oct 15;11(20):7328-33. doi: 10.1158/1078-0432.CCR-05-0507. Clin Cancer Res. 2005. PMID: 16243804

3

Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status.

Xu Y, Yao L, Li H, Ouyang T, Li J, Wang T, Fan Z, Lin B, Lu Y, Larsson O, Xie Y. Xu Y, et al. Among authors: xie y. Breast Cancer Res Treat. 2006 May;97(1):49-55. doi: 10.1007/s10549-005-9086-7. Breast Cancer Res Treat. 2006. PMID: 16319978

4

The association of CYP2D6 *10 polymorphism with breast cancer risk and clinico-pathologic characteristics in Chinese women.

Li H, Feng L, Xu Y, Yao L, Ouyang T, Li J, Wang T, Fan Z, Lin B, Li J, Xie Y. Li H, et al. Among authors: xie y. Acta Oncol. 2006;45(5):597-601. doi: 10.1080/02841860600660803. Acta Oncol. 2006. PMID: 16864175

5

Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer.

Guo J, Shou C, Meng L, Jiang B, Dong B, Yao L, Xie Y, Zhang J, Chen Y, Budman DR, Shi YE. Guo J, et al. Among authors: xie y. Int J Cancer. 2007 Sep 15;121(6):1296-305. doi: 10.1002/ijc.22763. Int J Cancer. 2007. PMID: 17534899

6

Effect of p53 codon 72 genotype on breast cancer survival depends on p53 gene status.

Xu Y, Yao L, Zhao A, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Lu Y, Xie Y. Xu Y, et al. Among authors: xie y. Int J Cancer. 2008 Jun 15;122(12):2761-6. doi: 10.1002/ijc.23454. Int J Cancer. 2008. PMID: 18348141

7

BRCA1 germline mutations and tumor characteristics in Chinese women with familial or early-onset breast cancer.

Chen W, Pan K, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Lu Y, You W, Xie Y. Chen W, et al. Among authors: xie y. Breast Cancer Res Treat. 2009 Sep;117(1):55-60. doi: 10.1007/s10549-008-0066-6. Epub 2008 May 30. Breast Cancer Res Treat. 2009. PMID: 18512148

8

BRCA1 promoter methylation associated with poor survival in Chinese patients with sporadic breast cancer.

Chen Y, Zhou J, Xu Y, Li Z, Wen X, Yao L, Xie Y, Deng D. Chen Y, et al. Among authors: xie y. Cancer Sci. 2009 Sep;100(9):1663-7. doi: 10.1111/j.1349-7006.2009.01225.x. Epub 2009 May 18. Cancer Sci. 2009. PMID: 19522853 Free PMC article.

9

[Prognostic role of apoptosis-related gene Fas-1377 and -670 polymorphisms in breast cancer].

Hu Y, Xu Y, Wang Y, Ouyang T, Li JF, Wang TF, Fan ZQ, Fan T, Lin BY, Geng PL, Xie YT. Hu Y, et al. Among authors: xie yt. Zhonghua Zhong Liu Za Zhi. 2009 Feb;31(2):104-7. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19538884 Chinese.

10

[Correlation of BRCA1 and APC aberrant methylation with the response to anthracycline-based neoadjuvant chemotherapy in primary breast cancer].

Yuan P, Xu Y, Ouyang T, Wang TF, Fan ZQ, Fan T, Lin BY, Xie YT, Li JF. Yuan P, et al. Among authors: xie yt. Zhonghua Zhong Liu Za Zhi. 2009 Apr;31(4):282-6. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19615284 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,269 results

Search Page

Filters